Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis

NCT05525520 is registered in ClinicalTrials.gov with Escient Pharmaceuticals, Inc as lead sponsor.

NCT NCT05525520
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05525520 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis
Lead sponsor
Escient Pharmaceuticals, Inc
Phase
Phase 2
Overall status
Completed
Start date
October 6, 2022
Completion date
September 5, 2024
Enrollment
62 (actual)
Sites
52

Conditions

As the registry lists them; a condition with its own page is linked.

pruritus